Implantable neuromodulation technology developer Neuspera Medical announced today that Steffen Hovard joined the company as CEO.
Hovard most recently served as president of Coloplast’s interventional urology arm. He had leadership responsibilities across four business areas within urological devices. At Coloplast, he oversaw 900 employees across 19 countries.
According to a news release, Hovard also serves as a board member for a number of medical device companies.
“I am delighted to have Steffen join and lead Neuspera as we look to bring our therapy platform to patients struggling with debilitating conditions such as UUI [urinary urgency incontinence],” said Mudit Jain of Treo Ventures, an investor in Neuspera. “He is an accomplished executive with an impressive record of leading multiple functions and driving significant growth in the urology space.”
Hovard joins just after Neuspera began enrollment for the second p…